Skip to main content
TipRanks
Go Ultimate75% OFF

Sotera Health (SHC) Capital Expenditure by Segment

197 Followers

Capital Expenditure by Segment

Sotera Health reported capital expenditure by segment of $52.84M in Q3 2026, up 13.7% from Q2 2026 and up 46.1% year over year. The highest value was $71.74M in Q4 2022.

Shows how Sotera allocates capital spending across its business units such as sterilization, lab testing, and support services. High capex in a segment signals capacity expansion and growth investment; low or steady capex may indicate mature operations or underinvestment. The capex mix affects future revenue potential, maintenance obligations, free cash flow, and whether spending is driven by regulatory compliance or efficiency projects that could improve margins.

$0.00$20.00M$40.00M$60.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Sterigenics is the clear capital focus — ongoing, H2‑weighted investments to expand capacity and upgrade EO systems are driving most of Sotera’s capex, while Nordion and Nelson Labs show smaller, lumpy spikes tied to Cobalt‑60 harvest timing and clean‑room projects. Management’s raised 2026 guidance and $200–$225M capex plan confirm these are growth investments, but expect higher depreciation and near‑term margin pressure; the company points to lower interest costs and improving leverage (3.0x trending toward 2–3x) to mitigate financing risk. Nordion remains timing‑sensitive, so shipment cadence can create revenue/capex volatility.

SHC Capital Expenditure by Segment

PeriodSterigenicsNordionNelson LabsTotal
Q3 2026Sep 30, 2026$44.58M$4.83M$3.42M$52.84M
Q2 2026Jun 30, 2026$39.52M$3.37M$3.56M$46.45M
Q1 2026Mar 31, 2026$37.89M$4.29M$3.98M$46.17M
Q4 2025Dec 31, 2025$34.51M$6.60M$9.59M$50.70M
Q3 2025Sep 30, 2025$28.37M$5.18M$2.63M$36.17M
Q2 2025Jun 30, 2025$20.11M$7.67M$3.46M$31.23M
Q1 2025Mar 31, 2025$16.39M$2.39M$1.13M$19.92M
Q4 2024Dec 31, 2024$47.28M$11.52M$7.07M$65.87M
Q3 2024Sep 30, 2024$30.18M$3.95M$2.27M$36.39M
Q2 2024Jun 30, 2024$31.52M$8.73M$1.67M$41.92M
Q1 2024Mar 31, 2024$22.27M$10.74M$1.88M$34.89M
Q4 2023Dec 31, 2023$47.60M$14.48M$2.75M$64.83M
Q3 2023Sep 30, 2023$41.71M$7.59M$2.71M$52.02M
Q2 2023Jun 30, 2023$42.85M$5.74M$4.55M$53.13M
Q1 2023Mar 31, 2023$30.88M$10.54M$3.58M$45.00M
Q4 2022Dec 31, 2022$53.58M$14.53M$3.62M$71.74M
Q3 2022Sep 30, 2022$29.84M$3.65M$2.60M$36.10M
Q2 2022Jun 30, 2022$35.38M$1.30M$2.32M$39.00M
Q1 2022Mar 31, 2022$25.22M$7.09M$3.23M$35.55M
Q4 2021Dec 31, 2021$25.20M$13.76M$2.30M$41.26M
Q3 2021Sep 30, 2021$12.70M$1.16M$2.25M$16.11M
Q2 2021Jun 30, 2021$16.34M$5.89M$1.62M$23.85M
Q1 2021Mar 31, 2021$19.51M$489.00K$939.00K$20.94M

Related KPIs